Research and Markets: The Future Of Enteral Nutrition: Key Players, Disease Specific Opportunities and Market Forecasts

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/2850b5/the_future_of_ente) has announced the addition of the "The Future Of Enteral Nutrition: Key Players, Disease Specific Opportunities and Market Forecasts" report to their offering.

“The Future Of Enteral Nutrition: Key Players, Disease Specific Opportunities and Market Forecasts”

Fuelled by an aging population and rising rates of illness, the clinical nutrition markets in the US, Canada and the EU continue to expand. Each of the five major product manufacturers are attempting to differentiate their offerings through the development of new products tailored specifically for certain patient groups. These products offer significantly greater nutritive benefits than more general products, offering manufacturers a means to establish leadership in these segments and capture share. Certain other companies, including start up enterprises, are also entering this market with unique new products.

This report analyzes the clinical nutrition market, identifying new product opportunities, and discusses how they will impact the market in the near and long term. The product development strategies of the leading manufacturers are analyzed and key opportunities are identified.

Key findings from this report

• Total sales of enteral nutrition products in the US, Canada and the EU reached $3.6bn in 2009. Of this, 41.2% was derived from US sales, while 3.2% was derived from Canada and the remaining 55.5% was obtained from the EU. Through 2014, total enteral nutrition product sales will rise by 7% per year to reach $5.1bn, reflecting continued downward pricing pressure. The greatest growth will occur in the EU, at 7.1% per year, followed by the US at 7% per year and Canada at 6.2% per year.
• Neuromuscular condition patients accounted for the greatest proportion of enteral nutrition sales in 2009, followed by cancer patients, nutritional depletion/malnutrition patients, surgery/burn patients, gastrointestinal disease patients, dialysis patients, immunotherapy patients and other patients.
• Although many enteral nutrition products may be considered multifunctional, in that they can be safely and effectively used in a wide variety of clinical situations, some newer products are being optimized for certain important disease states.
• In terms of new product opportunities in the near term, patient populations that are currently underserved include those suffering from obesity, diabetics, respiratory patients, seniors and persons with dysphagia. These groups also tend to have a life-long need for medical nutrition products, creating a significant market opportunity.

Key Topics Covered:

• Executive summary
• Introduction
• Enteral nutrition in the US and Canada
• Enteral nutrition in the EU
• Opportunities in enteral nutrition
• Chapter 1 Introduction
• Chapter 2 Enteral nutrition in the US and Canada
• Chapter 3 Enteral nutrition in the EU
• Chapter 4 Opportunities in enteral nutrition
• Table of figures
• Table of tables

Companies Mentioned:

• Abbott
• B. Braun
• Danone
• Fresenius Kabi
• Nestl

For more information visit http://www.researchandmarkets.com/research/2850b5/the_future_of_ente

Source: Business Insights